₩68700.00
₩0.00 (0.00%)
End-of-day quote: 05/17/2024
KOSDAQ:A141080
LegoChem Biosciences Annual Report
Year | Year | 2023 | 2022 | 2021 | 2020 | 2015 | ||
---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
₩34.15B | ₩33.41B | ₩32.16B | ₩0.00M | ₩1.79B | |
GM % | Gross Margin % |
|
52.12% | 53.42% | 55.03% | 0.00% | 61.37% | |
OM | Operating Margin |
|
-236.70% | -150.77% | -86.16% | 0.00% | 0.00% | |
EPS | Earnings Per Share |
|
₩0.00 | ₩-3279.00 | ₩-1845.00 | ₩-970.00 | ₩-307.00 | ₩-343.39 |
Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | |
Sha. | Shares |
|
27.98m | 25.5m | 24.23m | 23.68m | 18.09m | |
OCF | Operating Cash Flow |
|
₩-62235.79M | ₩-7135.57M | ₩-42048.76M | ₩0.00M | ₩-8780.26M | |
FCF | Free Cash Flow |
|
₩-67333.33M | ₩-18700.00M | ₩-60357.74M | ₩-17632.83M | ₩-9145.27M | |
FCFS | Free Cash Flow Per Share |
|
₩-2268.62 | ₩-488.76 | ₩-2507.47 | ₩0.00 | ₩-592.30 |